Viewing Study NCT00003757


Ignite Creation Date: 2025-12-24 @ 6:54 PM
Ignite Modification Date: 2025-12-25 @ 10:20 PM
Study NCT ID: NCT00003757
Status: COMPLETED
Last Update Posted: 2012-05-15
First Post: 1999-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Rituximab in Treating Patients With Refractory or Recurrent Hairy Cell Leukemia Following Cladribine Therapy
Sponsor: Swiss Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module